Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology

Restricted access

Cervical cancer is a malignant epithelial tumor that forms in the uterine cervix. Most cases of cervical cancer are preventable through human papilloma virus (HPV) vaccination, routine screening, and treatment of precancerous lesions. However, due to inadequate screening protocols in many regions of the world, cervical cancer remains the fourth-most common cancer in women globally. The complete NCCN Guidelines for Cervical Cancer provide recommendations for the diagnosis, evaluation, and treatment of cervical cancer. This manuscript discusses guiding principles for the workup, staging, and treatment of early stage and locally advanced cervical cancer, as well as evidence for these recommendations. For recommendations regarding treatment of recurrent or metastatic disease, please see the full guidelines on NCCN.org.

Discussion Section Writing Committee.

PLEASE NOTE

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) are a statement of evidence and consensus of the authors regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult the NCCN Guidelines is expected to use independent medical judgment in the context of individual clinical circumstances to determine any patient's care or treatment. The National Comprehensive Cancer Network® (NCCN®) makes no representations or warranties of any kind regarding their content, use, or application and disclaims any responsibility for their applications or use in any way.

The complete NCCN Guidelines for Cervical Cancer are not printed in this issue of JNCCN but can be accessed online at NCCN.org.

© National Comprehensive Cancer Network, Inc. 2019. All rights reserved. The NCCN Guidelines and the illustrations herein may not be reproduced in any form without the express written permission of NCCN.

Disclosures for the NCCN Cervical Cancer Panel

At the beginning of each NCCN Guidelines Panel meeting, panel members review all potential conflicts of interest. NCCN, in keeping with its commitment to public transparency, publishes these disclosures for panel members, staff, and NCCN itself.

Individual disclosures for the NCCN Cervical Cancer Panel members can be found on page 84. (The most recent version of these guidelines and accompanying disclosures are available on the NCCN website at NCCN.org.)

The complete and most recent version of these guidelines are available free of charge at NCCN.org

  • 1.

    Amit A, Schink J, Reiss A, Lowenstein L. PET/CT in gynecologic cancer: present applications and future prospects--a clinician's perspective. Obstet Gynecol Clin North Am 2011;38:121, vii.

    • Search Google Scholar
    • Export Citation
  • 2.

    Patel S, Liyanage SH, Sahdev A. Imaging of endometrial and cervical cancer. Insights Imaging 2010;1:309328.

  • 3.

    ACOG practice bulletin. Diagnosis and treatment of cervical carcinomas. Number 35, May 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002;78:7991.

    • Search Google Scholar
    • Export Citation
  • 4.

    Gold MA, Tian C, Whitney CW. Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study. Cancer 2008;112:19541963.

    • Search Google Scholar
    • Export Citation
  • 5.

    Monk BJ, Tian C, Rose PG, Lanciano R. Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials. Gynecol Oncol 2007;105:427433.

    • Search Google Scholar
    • Export Citation
  • 6.

    Sherman ME, Wang SS, Carreon J, Devesa SS. Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival. Cancer 2005;103:12581264.

    • Search Google Scholar
    • Export Citation
  • 7.

    Sasieni P, Castanon A, Cuzick J. Screening and adenocarcinoma of the cervix. Int J Cancer 2009;125:525529.

  • 8.

    Siegel CL, Andreotti RF, Cardenes HR. ACR Appropriateness Criteria(R) pretreatment planning of invasive cancer of the cervix. J Am Coll Radiol 2012;9:395402.

    • Search Google Scholar
    • Export Citation
  • 9.

    Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet 2009;105:107108.

  • 10.

    Moore DH. Surgical staging and cervical cancer: after 30 years, have we reached a conclusion? Cancer 2008;112:18741876.

  • 11.

    Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009;105:103104.

  • 12.

    Cervix Uteri Cancer Staging. American Joint Committee on Cancer; Available at: http://cancerstaging.org/references-tools/quickreferences/Documents/CervixMedium.pdf. Accessed July 3, 2014.

    • Search Google Scholar
    • Export Citation
  • 13.

    How is cervical cancer staged? American Cancer Society; 2014. Available at: http://www.cancer.org/acs/groups/cid/documents/webcontent/003094-pdf.pdf. Accessed July 3, 2014.

    • Search Google Scholar
    • Export Citation
  • 14.

    Hricak H, Gatsonis C, Coakley FV. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation—ACRIN/GOG comparative study of diagnostic performance and interobserver variability. Radiology 2007;245:491498.

    • Search Google Scholar
    • Export Citation
  • 15.

    Woo S, Kim HS, Chung HH. Early stage cervical cancer: role of magnetic resonance imaging after conization in determining residual tumor. Acta Radiol 2016;57:12681276.

    • Search Google Scholar
    • Export Citation
  • 16.

    Mitchell DG, Snyder B, Coakley F. Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study. J Clin Oncol 2006;24:56875694.

    • Search Google Scholar
    • Export Citation
  • 17.

    Downey K, Jafar M, Attygalle AD. Influencing surgical management in patients with carcinoma of the cervix using a T2- and ZOOM-diffusion-weighted endovaginal MRI technique. Br J Cancer 2013;109:615622.

    • Search Google Scholar
    • Export Citation
  • 18.

    Lakhman Y, Akin O, Park KJ. Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy. Radiology 2013;269:149158.

    • Search Google Scholar
    • Export Citation
  • 19.

    Downey K, Shepherd JH, Attygalle AD. Preoperative imaging in patients undergoing trachelectomy for cervical cancer: validation of a combined T2- and diffusion-weighted endovaginal MRI technique at 3.0 T. Gynecol Oncol 2014;133:326332.

    • Search Google Scholar
    • Export Citation
  • 20.

    de Boer P, Adam JA, Buist MR. Role of MRI in detecting involvement of the uterine internal os in uterine cervical cancer: systematic review of diagnostic test accuracy. Eur J Radiol 2013;82:e422428.

    • Search Google Scholar
    • Export Citation
  • 21.

    Thomeer MG, Gerestein C, Spronk S. Clinical examination versus magnetic resonance imaging in the pretreatment staging of cervical carcinoma: systematic review and meta-analysis. Eur Radiol 2013;23:20052018.

    • Search Google Scholar
    • Export Citation
  • 22.

    Park JY, Kim EN, Kim DY. Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer. Gynecol Oncol 2008;108:486492.

    • Search Google Scholar
    • Export Citation
  • 23.

    Lin SY, Tsai CS, Chang YC. The role of pretreatment FDG-PET in treating cervical cancer patients with enlarged pelvic lymph node(s) shown on MRI: a phase 3 randomized trial with long-term follow-up. Int J Radiat Oncol Biol Phys 2015;92:577585.

    • Search Google Scholar
    • Export Citation
  • 24.

    Boughanim M, Leboulleux S, Rey A. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area. J Clin Oncol 2008;26:25582561.

    • Search Google Scholar
    • Export Citation
  • 25.

    Zhao Q, Feng Y, Mao X, Qie M. Prognostic value of fluorine-18-fluorodeoxyglucose positron emission tomography or PET-computed tomography in cervical cancer: a meta-analysis. Int J Gynecol Cancer 2013;23:11841190.

    • Search Google Scholar
    • Export Citation
  • 26.

    Gee MS, Atri M, Bandos AI. Identification of distant metastatic disease in uterine cervical and endometrial cancers with FDG PET/CT: analysis from the ACRIN 6671/GOG 0233 Multicenter Trial. Radiology 2018;287:176184.

    • Search Google Scholar
    • Export Citation
  • 27.

    Sedlis A, Bundy BN, Rotman MZ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Gynecol Oncol 1999;73:177183.

    • Search Google Scholar
    • Export Citation
  • 28.

    Ryu SY, Kim MH, Nam BH. Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: a Korean Gynecologic Oncology Group study. Br J Cancer 2014;110:278285.

    • Search Google Scholar
    • Export Citation
  • 29.

    Noh JM, Park W, Kim YS. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13–10). Gynecol Oncol 2014;132:618623.

    • Search Google Scholar
    • Export Citation
  • 30.

    Diaz ES, Aoyama C, Baquing MA. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins. Gynecol Oncol 2014;132:7680.

    • Search Google Scholar
    • Export Citation
  • 31.

    Estape RE, Angioli R, Madrigal M. Close vaginal margins as a prognostic factor after radical hysterectomy. Gynecol Oncol 1998;68:229232.

  • 32.

    Parra-Herran C, Taljaard M, Djordjevic B. Pattern-based classification of invasive endocervical adenocarcinoma, depth of invasion measurement and distinction from adenocarcinoma in situ: interobserver variation among gynecologic pathologists. Mod Pathol 2016;29:879892.

    • Search Google Scholar
    • Export Citation
  • 33.

    Roma AA, Mistretta TA, Diaz De Vivar A. New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome. Gynecol Oncol 2016;141:3642.

    • Search Google Scholar
    • Export Citation
  • 34.

    Rutgers JK, Roma AA, Park KJ. Pattern classification of endocervical adenocarcinoma: reproducibility and review of criteria. Mod Pathol 2016;29:10831094.

    • Search Google Scholar
    • Export Citation
  • 35.

    Bentivegna E, Gouy S, Maulard A. Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review. Lancet Oncol 2016;17:e240253.

    • Search Google Scholar
    • Export Citation
  • 36.

    Ueki M, Okamoto Y, Misaki O. Conservative therapy for microinvasive carcinoma of the uterine cervix. Gynecol Oncol 1994;53:109113.

  • 37.

    Al-Kalbani M, McVeigh G, Nagar H, McCluggage WG. Do FIGO stage IA and small ( Int J Gynecol Cancer 2012;22:291295.

  • 38.

    Webb JC, Key CR, Qualls CR, Smith HO. Population-based study of microinvasive adenocarcinoma of the uterine cervix. Obstet Gynecol 2001;97:701706.

    • Search Google Scholar
    • Export Citation
  • 39.

    Sevin BU, Nadji M, Averette HE. Microinvasive carcinoma of the cervix. Cancer 1992;70:21212128.

  • 40.

    Huang LW, Hwang JL. A comparison between loop electrosurgical excision procedure and cold knife conization for treatment of cervical dysplasia: residual disease in a subsequent hysterectomy specimen. Gynecol Oncol 1999;73:1215.

    • Search Google Scholar
    • Export Citation
  • 41.

    Miroshnichenko GG, Parva M, Holtz DO. Interpretability of excisional biopsies of the cervix: cone biopsy and loop excision. J Low Genit Tract Dis 2009;13:1012.

    • Search Google Scholar
    • Export Citation
  • 42.

    Greenspan DL, Faubion M, Coonrod DV. Compliance after loop electrosurgical excision procedure or cold knife cone biopsy. Obstet Gynecol 2007;110:675680.

    • Search Google Scholar
    • Export Citation
  • 43.

    Fanning J, Padratzik J. Cold knife conization vs. LEEP. Are they the same procedure? J Reprod Med 2002;47:3335.

  • 44.

    Simmons JR, Anderson L, Hernandez E, Heller PB. Evaluating cervical neoplasia. LEEP as an alternative to cold knife conization. J Reprod Med 1998;43:10071013.

    • Search Google Scholar
    • Export Citation
  • 45.

    Kim MK, Kim MA, Kim JW. Loop electrosurgical excision procedure findings for identification of patients with early-stage cervical cancer suitable for less radical surgery. Int J Gynecol Cancer 2012;22:12141219.

    • Search Google Scholar
    • Export Citation
  • 46.

    Bouchard-Fortier G, Reade CJ, Covens A. Non-radical surgery for small early-stage cervical cancer. Is it time? Gynecol Oncol 2014;132:624627.

    • Search Google Scholar
    • Export Citation
  • 47.

    Kato T, Takashima A, Kasamatsu T. Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A). Gynecol Oncol 2015;137:3439.

    • Search Google Scholar
    • Export Citation
  • 48.

    Diaz JP, Sonoda Y, Leitao MM. Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma. Gynecol Oncol 2008;111:255260.

    • Search Google Scholar
    • Export Citation
  • 49.

    Abu-Rustum NR, Tal MN, DeLair D. Radical abdominal trachelectomy for stage IB1 cervical cancer at 15-week gestation. Gynecol Oncol 2010;116:151152.

    • Search Google Scholar
    • Export Citation
  • 50.

    Ramirez PT, Pareja R, Rendon GJ. Management of low-risk early-stage cervical cancer: should conization, simple trachelectomy, or simple hysterectomy replace radical surgery as the new standard of care? Gynecol Oncol 2014;132:254259.

    • Search Google Scholar
    • Export Citation
  • 51.

    Dargent D, Martin X, Sacchetoni A, Mathevet P. Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients. Cancer 2000;88:18771882.

    • Search Google Scholar
    • Export Citation
  • 52.

    Viswanathan AN, Deavers MT, Jhingran A. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol 2004;93:2733.

    • Search Google Scholar
    • Export Citation
  • 53.

    Young RH, Clement PB. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis. Histopathology 2002;41:185207.

    • Search Google Scholar
    • Export Citation
  • 54.

    Cao DY, Yang JX, Wu XH. Comparisons of vaginal and abdominal radical trachelectomy for early-stage cervical cancer: preliminary results of a multi-center research in China. Br J Cancer 2013;109:27782782.

    • Search Google Scholar
    • Export Citation
  • 55.

    Plante M, Gregoire J, Renaud MC, Roy M. The vaginal radical trachelectomy: an update of a series of 125 cases and 106 pregnancies. Gynecol Oncol 2011;121:290297.

    • Search Google Scholar
    • Export Citation
  • 56.

    Abu-Rustum NR, Sonoda Y, Black D. Fertility-sparing radical abdominal trachelectomy for cervical carcinoma: technique and review of the literature. Gynecol Oncol 2006;103:807813.

    • Search Google Scholar
    • Export Citation
  • 57.

    Einstein MH, Park KJ, Sonoda Y. Radical vaginal versus abdominal trachelectomy for stage IB1 cervical cancer: a comparison of surgical and pathologic outcomes. Gynecol Oncol 2009;112:7377.

    • Search Google Scholar
    • Export Citation
  • 58.

    Wethington SL, Cibula D, Duska LR. An international series on abdominal radical trachelectomy: 101 patients and 28 pregnancies. Int J Gynecol Cancer 2012;22:12511257.

    • Search Google Scholar
    • Export Citation
  • 59.

    Abu-Rustum NR, Sonoda Y. Fertility-sparing surgery in early-stage cervical cancer: indications and applications. J Natl Compr Canc Netw 2010;8:14351438.

    • Search Google Scholar
    • Export Citation
  • 60.

    Beiner ME, Covens A. Surgery insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer. Nat Clin Pract Oncol 2007;4:353361.

    • Search Google Scholar
    • Export Citation
  • 61.

    Pareja R, Rendon GJ, Sanz-Lomana CM. Surgical, oncological, and obstetrical outcomes after abdominal radical trachelectomy—a systematic literature review. Gynecol Oncol 2013;131:7782.

    • Search Google Scholar
    • Export Citation
  • 62.

    Lintner B, Saso S, Tarnai L. Use of abdominal radical trachelectomy to treat cervical cancer greater than 2 cm in diameter. Int J Gynecol Cancer 2013;23:10651070.

    • Search Google Scholar
    • Export Citation
  • 63.

    Wethington SL, Sonoda Y, Park KJ. Expanding the indications for radical trachelectomy: a report on 29 patients with stage IB1 tumors measuring 2 to 4 centimeters. Int J Gynecol Cancer 2013;23:10921098.

    • Search Google Scholar
    • Export Citation
  • 64.

    Lanowska M, Mangler M, Speiser D. Radical vaginal trachelectomy after laparoscopic staging and neoadjuvant chemotherapy in women with early-stage cervical cancer over 2 cm: oncologic, fertility, and neonatal outcome in a series of 20 patients. Int J Gynecol Cancer 2014;24:586593.

    • Search Google Scholar
    • Export Citation
  • 65.

    Shepherd JH, Spencer C, Herod J, Ind TEJ. Radical vaginal trachelectomy as a fertility-sparing procedure in women with early-stage cervical cancer-cumulative pregnancy rate in a series of 123 women. BJOG 2006;113:719724.

    • Search Google Scholar
    • Export Citation
  • 66.

    Park JY, Kim DY, Suh DS. Reproductive outcomes after laparoscopic radical trachelectomy for early-stage cervical cancer. J Gynecol Oncol 2014;25:913.

    • Search Google Scholar
    • Export Citation
  • 67.

    Gizzo S, Ancona E, Saccardi C. Radical trachelectomy: the first step of fertility preservation in young women with cervical cancer (review). Oncol Rep 2013;30:25452554.

    • Search Google Scholar
    • Export Citation
  • 68.

    Cibula D, Abu-Rustum NR, Benedetti-Panici P. New classification system of radical hysterectomy: emphasis on a three-dimensional anatomic template for parametrial resection. Gynecol Oncol 2011;122:264268.

    • Search Google Scholar
    • Export Citation
  • 69.

    Querleu D, Morrow CP. Classification of radical hysterectomy. Lancet Oncol 2008;9:297303.

  • 70.

    Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974;44:265272.

  • 71.

    Chi DS, Abu-Rustum NR, Plante M, Roy M. Cancer of the cervix. In: Rock JA, Jones HW, eds, eds. TeLinde's Operative Gynecology, 10th ed. Philadelphia: Lippincott Williams and Wilkins; 2008:1227.

    • Search Google Scholar
    • Export Citation
  • 72.

    Whitney CW, Spirtos NM. Gynecologic Oncology Group Surgical Procedures Manual. Philadelphia: Gynecologic Oncology Group; 2009. Available at: https://gogmember.gog.org/manuals/pdf/surgman.pdf. Accessed April 18, 2014.

    • Search Google Scholar
    • Export Citation
  • 73.

    Sardain H, Lavoue V, Redpath M. Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review. Eur J Surg Oncol 2015;41:975985.

    • Search Google Scholar
    • Export Citation
  • 74.

    Chiantera V, Rossi M, De Iaco P. Morbidity after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 230 patients. Int J Gynecol Cancer 2014;24:156164.

    • Search Google Scholar
    • Export Citation
  • 75.

    Cormier B, Diaz JP, Shih K. Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer. Gynecol Oncol 2011;122:275280.

    • Search Google Scholar
    • Export Citation
  • 76.

    Lecuru F, Mathevet P, Querleu D. Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol 2011;29:16861691.

    • Search Google Scholar
    • Export Citation
  • 77.

    Altgassen C, Hertel H, Brandstadt A. Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. J Clin Oncol 2008;26:29432951.

    • Search Google Scholar
    • Export Citation
  • 78.

    Bats AS, Buenerd A, Querleu D. Diagnostic value of intraoperative examination of sentinel lymph node in early cervical cancer: a prospective, multicenter study. Gynecol Oncol 2011;123:230235.

    • Search Google Scholar
    • Export Citation
  • 79.

    Bats AS, Mathevet P, Buenerd A. The sentinel node technique detects unexpected drainage pathways and allows nodal ultrastaging in early cervical cancer: insights from the multicenter prospective SENTICOL study. Ann Surg Oncol 2013;20:413422.

    • Search Google Scholar
    • Export Citation
  • 80.

    Cibula D, Abu-Rustum NR, Dusek L. Bilateral ultrastaging of sentinel lymph node in cervical cancer: Lowering the false-negative rate and improving the detection of micrometastasis. Gynecol Oncol 2012;127:462466.

    • Search Google Scholar
    • Export Citation
  • 81.

    Cibula D, Abu-Rustum NR, Dusek L. Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. Gynecol Oncol 2012;124:496501.

    • Search Google Scholar
    • Export Citation
  • 82.

    Fader AN, Edwards RP, Cost M. Sentinel lymph node biopsy in early-stage cervical cancer: utility of intraoperative versus postoperative assessment. Gynecol Oncol 2008;111:1317.

    • Search Google Scholar
    • Export Citation
  • 83.

    Lecuru F, Bats A, Mathevet P. Impact of sentinel lymph node biopsy on staging of early cervical cancer: Results of a prospective, multicenter study [abstract]. J Clin Oncol 2009;27(Suppl 18):Abstract CRA5506.

    • Search Google Scholar
    • Export Citation
  • 84.

    Slama J, Dundr P, Dusek L, Cibula D. High false negative rate of frozen section examination of sentinel lymph nodes in patients with cervical cancer. Gynecol Oncol 2013;129:384388.

    • Search Google Scholar
    • Export Citation
  • 85.

    van de Lande J, Torrenga B, Raijmakers PGHM. Sentinel lymph node detection in early stage uterine cervix carcinoma: a systematic review. Gynecol Oncol 2007;106:604613.

    • Search Google Scholar
    • Export Citation
  • 86.

    Andikyan V, Khoury-Collado F, Denesopolis J. Cervical conization and sentinel lymph node mapping in the treatment of stage I cervical cancer: is less enough? Int J Gynecol Cancer 2014;24:113117.

    • Search Google Scholar
    • Export Citation
  • 87.

    Wu Y, Li Z, Wu H, Yu J. Sentinel lymph node biopsy in cervical cancer: a meta-analysis. Mol Clin Oncol 2013;1:10251030.

  • 88.

    Kadkhodayan S, Hasanzadeh M, Treglia G. Sentinel node biopsy for lymph nodal staging of uterine cervix cancer: a systematic review and meta-analysis of the pertinent literature. Eur J Surg Oncol 2015;41:120.

    • Search Google Scholar
    • Export Citation
  • 89.

    Ruscito I, Gasparri ML, Braicu EI. Sentinel node mapping in cervical and endometrial cancer: indocyanine green versus other conventional dyes—a meta-analysis. Ann Surg Oncol 2016;23:37493756.

    • Search Google Scholar
    • Export Citation
  • 90.

    Frumovitz M, Plante M, Lee PS. The FILM Trial: a randomized phase III multicenter study assessing near infrared fluorescence in the identification of sentinel lymph nodes (SLN) [Abstract]. Gynecologic Oncology 2018;149:7.

    • Search Google Scholar
    • Export Citation
  • 91.

    Eiriksson LR, Covens A. Sentinel lymph node mapping in cervical cancer: the future? BJOG 2012;119:129133.

  • 92.

    Bats AS, Frati A, Mathevet P. Contribution of lymphoscintigraphy to intraoperative sentinel lymph node detection in early cervical cancer: analysis of the prospective multicenter SENTICOL cohort. Gynecol Oncol 2015;137:264269.

    • Search Google Scholar
    • Export Citation
  • 93.

    Darlin L, Persson J, Bossmar T. The sentinel node concept in early cervical cancer performs well in tumors smaller than 2 cm. Gynecol Oncol 2010;117:266269.

    • Search Google Scholar
    • Export Citation
  • 94.

    Sakuragi N, Satoh C, Takeda N. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer 1999;85:15471554.

    • Search Google Scholar
    • Export Citation
  • 95.

    Huang H, Liu J, Li Y. Metastasis to deep obturator and para-aortic lymph nodes in 649 patients with cervical carcinoma. Eur J Surg Oncol 2011;37:978983.

    • Search Google Scholar
    • Export Citation
  • 96.

    Gouy S, Morice P, Narducci F. Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging. J Clin Oncol 2013;31:30263033.

    • Search Google Scholar
    • Export Citation
  • 97.

    Frumovitz M, Querleu D, Gil-Moreno A. Lymphadenectomy in locally advanced cervical cancer study (LiLACS): Phase III clinical trial comparing surgical with radiologic staging in patients with stages IB2IVA cervical cancer. J Minim Invasive Gynecol 2014;21:38.

    • Search Google Scholar
    • Export Citation
  • 98.

    Chen Y, Xu H, Li Y. The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer: a prospective analysis of 295 patients. Ann Surg Oncol 2008;15:28472855.

    • Search Google Scholar
    • Export Citation
  • 99.

    Puntambekar SP, Palep RJ, Puntambekar SS. Laparoscopic total radical hysterectomy by the Pune technique: our experience of 248 cases. J Minim Invasive Gynecol 2007;14:682689.

    • Search Google Scholar
    • Export Citation
  • 100.

    Nam JH, Park JY, Kim DY. Laparoscopic versus open radical hysterectomy in early-stage cervical cancer: long-term survival outcomes in a matched cohort study. Ann Oncol 2012;23:903911.

    • Search Google Scholar
    • Export Citation
  • 101.

    Wang YZ, Deng L, Xu HC. Laparoscopy versus laparotomy for the management of early stage cervical cancer. BMC Cancer 2015;15:928.

  • 102.

    Sert BM, Boggess JF, Ahmad S. Robot-assisted versus open radical hysterectomy: a multi-institutional experience for early-stage cervical cancer. Eur J Surg Oncol 2016;42:513522.

    • Search Google Scholar
    • Export Citation
  • 103.

    Mendivil AA, Rettenmaier MA, Abaid LN. Survival rate comparisons amongst cervical cancer patients treated with an open, robotic-assisted or laparoscopic radical hysterectomy: a five year experience. Surg Oncol 2016;25:6671.

    • Search Google Scholar
    • Export Citation
  • 104.

    Park DA, Yun JE, Kim SW, Lee SH. Surgical and clinical safety and effectiveness of robot-assisted laparoscopic hysterectomy compared to conventional laparoscopy and laparotomy for cervical cancer: a systematic review and meta-analysis. Eur J Surg Oncol 2017;43:9941002.

    • Search Google Scholar
    • Export Citation
  • 105.

    Shazly SA, Murad MH, Dowdy SC. Robotic radical hysterectomy in early stage cervical cancer: a systematic review and meta-analysis. Gynecol Oncol 2015;138:457471.

    • Search Google Scholar
    • Export Citation
  • 106.

    Ramirez PT, Frumovitz M, Pareja R. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med 2018;379:18951904.

    • Search Google Scholar
    • Export Citation
  • 107.

    Melamed A, Margul DJ, Chen L. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer. N Engl J Med 2018;379:19051914.

    • Search Google Scholar
    • Export Citation
  • 108.

    Margul DJ, Yang J, Seagle BL. Outcomes and costs of open, robotic, and laparoscopic radical hysterectomy for stage IB1 cervical cancer. J Clin Oncol 2018;36:5502.

    • Search Google Scholar
    • Export Citation
  • 109.

    Nevis IF, Vali B, Higgins C. Robot-assisted hysterectomy for endometrial and cervical cancers: a systematic review. J Robot Surg 2016.

  • 110.

    Lowe MP, Chamberlain DH, Kamelle SA. A multi-institutional experience with robotic-assisted radical hysterectomy for early stage cervical cancer. Gynecol Oncol 2009;113:191194.

    • Search Google Scholar
    • Export Citation
  • 111.

    Nezhat FR, Datta MS, Liu C. Robotic radical hysterectomy versus total laparoscopic radical hysterectomy with pelvic lymphadenectomy for treatment of early cervical cancer. JSLS 2008;12:227237.

    • Search Google Scholar
    • Export Citation
  • 112.

    Cantrell LA, Mendivil A, Gehrig PA, Boggess JF. Survival outcomes for women undergoing type III robotic radical hysterectomy for cervical cancer: a 3-year experience. Gynecol Oncol 2010;117:260265.

    • Search Google Scholar
    • Export Citation
  • 113.

    Gaffney DK, Erickson-Wittmann BA, Jhingran A. ACR Appropriateness Criteria(R) on advanced cervical cancer expert panel on radiation oncology-gynecology. Int J Radiat Oncol Biol Phys 2011;81:609614.

    • Search Google Scholar
    • Export Citation
  • 114.

    Monk BJ, Tewari KS, Koh W-J. Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol 2007;25:29522965.

    • Search Google Scholar
    • Export Citation
  • 115.

    Gien LT, Beauchemin MC, Thomas G. Adenocarcinoma: a unique cervical cancer. Gynecol Oncol 2010;116:140146.

  • 116.

    Baalbergen A, Veenstra Y, Stalpers LL, Ansink AC. Primary surgery versus primary radiation therapy with or without chemotherapy for early adenocarcinoma of the uterine cervix. Cochrane Database Syst Rev 2010:CD006248.

    • Search Google Scholar
    • Export Citation
  • 117.

    Park JY, Kim DY, Kim JH. Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix. Br J Cancer 2010;102:16921698.

    • Search Google Scholar
    • Export Citation
  • 118.

    Wo JY, Viswanathan AN. Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys 2009;73:13041312.

    • Search Google Scholar
    • Export Citation
  • 119.

    Pahisa J, Martinez-Roman S, Martinez-Zamora MA. Laparoscopic ovarian transposition in patients with early cervical cancer. Int J Gynecol Cancer 2008;18:584589.

    • Search Google Scholar
    • Export Citation
  • 120.

    Morice P, Juncker L, Rey A. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril 2000;74:743748.

    • Search Google Scholar
    • Export Citation
  • 121.

    Landoni F, Maneo A, Colombo A. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997;350:535540.

    • Search Google Scholar
    • Export Citation
  • 122.

    Keys HM, Bundy BN, Stehman FB. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:11541161.

    • Search Google Scholar
    • Export Citation
  • 123.

    Morris M, Eifel PJ, Lu J. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:11371143.

    • Search Google Scholar
    • Export Citation
  • 124.

    Peters WA, Liu PY, Barrett RJ. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:16061613.

    • Search Google Scholar
    • Export Citation
  • 125.

    Whitney CW, Sause W, Bundy BN. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:13391348.

    • Search Google Scholar
    • Export Citation
  • 126.

    Rose PG, Bundy BN, Watkins EB. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:11441153.

    • Search Google Scholar
    • Export Citation
  • 127.

    Thomas GM. Improved treatment for cervical cancer—concurrent chemotherapy and radiotherapy. N Engl J Med 1999;340:11981200.

  • 128.

    Rose PG, Ali S, Watkins E. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study. J Clin Oncol 2007;25:28042810.

    • Search Google Scholar
    • Export Citation
  • 129.

    Eifel PJ, Winter K, Morris M. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004;22:872880.

    • Search Google Scholar
    • Export Citation
  • 130.

    Stehman FB, Ali S, Keys HM. Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial. Am J Obstet Gynecol 2007;197:16.

    • Search Google Scholar
    • Export Citation
  • 131.

    Chemoradiotherapy for Cervical Cancer Meta-Analysis C. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;26:58025812.

    • Search Google Scholar
    • Export Citation
  • 132.

    Pearcey R, Miao Q, Kong W. Impact of adoption of chemoradiotherapy on the outcome of cervical cancer in Ontario: results of a population-based cohort study. J Clin Oncol 2007;25:23832388.

    • Search Google Scholar
    • Export Citation
  • 133.

    King M, McConkey C, Latief TN. Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects. Clin Oncol (R Coll Radiol) 2006;18:3845.

    • Search Google Scholar
    • Export Citation
  • 134.

    Tan LT, Zahra M. Long-term survival and late toxicity after chemoradiotherapy for cervical cancer—the Addenbrooke's experience. Clin Oncol (R Coll Radiol) 2008;20:358364.

    • Search Google Scholar
    • Export Citation
  • 135.

    Gaffney DK, Du Bois A, Narayan K. Practice patterns of radiotherapy in cervical cancer among member groups of the Gynecologic Cancer Intergroup (GCIG). Int J Radiat Oncol Biol Phys 2007;68:485490.

    • Search Google Scholar
    • Export Citation
  • 136.

    Cetina L, Garcia-Arias A, Uribe MdJ. Concurrent chemoradiation with carboplatin for elderly, diabetic and hypertensive patients with locally advanced cervical cancer. Eur J Gynaecol Oncol 2008;29:608612.

    • Search Google Scholar
    • Export Citation
  • 137.

    Dubay RA, Rose PG, O'Malley DM. Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer. Gynecol Oncol 2004;94:121124.

    • Search Google Scholar
    • Export Citation
  • 138.

    Higgins RV, Naumann WR, Hall JB, Haake M. Concurrent carboplatin with pelvic radiation therapy in the primary treatment of cervix cancer. Gynecol Oncol 2003;89:499503.

    • Search Google Scholar
    • Export Citation
  • 139.

    Lorvidhaya V, Chitapanarux I, Sangruchi S. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial. Int J Radiat Oncol Biol Phys 2003;55:12261232.

    • Search Google Scholar
    • Export Citation
  • 140.

    Wong LC, Ngan HY, Cheung AN. Chemoradiation and adjuvant chemotherapy in cervical cancer. J Clin Oncol 1999;17:20552060.

  • 141.

    Tharavichitkul E, Lorvidhaya V, Kamnerdsupaphon P. Combined chemoradiation of cisplatin versus carboplatin in cervical carcinoma: a single institution experience from Thailand. BMC Cancer 2016;16:501.

    • Search Google Scholar
    • Export Citation
  • 142.

    Mileshkin LR, Narayan K, Moore KN. A phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: Outback (ANZGOG0902/GOG0274/RTOG1174) [abstract]. J Clin Oncol 2014 32:abstract TPS5632.

    • Search Google Scholar
    • Export Citation
  • 143.

    Koliopoulos G, Sotiriadis A, Kyrgiou M. Conservative surgical methods for FIGO stage IA2 squamous cervical carcinoma and their role in preserving women's fertility. Gynecol Oncol 2004;93:469473.

    • Search Google Scholar
    • Export Citation
  • 144.

    Wright JD, NathavithArana R, Lewin SN. Fertility-conserving surgery for young women with stage IA1 cervical cancer: safety and access. Obstet Gynecol 2010;115:585590.

    • Search Google Scholar
    • Export Citation
  • 145.

    Tierney KE, Lin PS, Amezcua C. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease. Am J Obstet Gynecol 2014;210:366 e361–365.

    • Search Google Scholar
    • Export Citation
  • 146.

    Yoneda JY, Braganca JF, Sarian LO. Surgical treatment of microinvasive cervical cancer: analysis of pathologic features with implications on radicality. Int J Gynecol Cancer 2015;25:694698.

    • Search Google Scholar
    • Export Citation
  • 147.

    Bernardini M, Barrett J, Seaward G, Covens A. Pregnancy outcomes in patients after radical trachelectomy. Am J Obstet Gynecol 2003;189:13781382.

    • Search Google Scholar
    • Export Citation
  • 148.

    Boss EA, van Golde RJT, Beerendonk CCM, Massuger LFAG. Pregnancy after radical trachelectomy: a real option? Gynecol Oncol 2005;99:152156.

  • 149.

    Plante M, Renaud M-C, Hoskins IA, Roy M. Vaginal radical trachelectomy: a valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature. Gynecol Oncol 2005;98:310.

    • Search Google Scholar
    • Export Citation
  • 150.

    Marchiole P, Benchaib M, Buenerd A. Oncological safety of laparoscopic-assisted vaginal radical trachelectomy (LARVT or Dargent's operation): a comparative study with laparoscopic-assisted vaginal radical hysterectomy (LARVH). Gynecol Oncol 2007;106:132141.

    • Search Google Scholar
    • Export Citation
  • 151.

    Landoni F, Zanagnolo V, Lovato-Diaz L. Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study). Int J Gynecol Cancer 2007;17:623628.

    • Search Google Scholar
    • Export Citation
  • 152.

    Shimada M, Kigawa J, Nishimura R. Ovarian metastasis in carcinoma of the uterine cervix. Gynecol Oncol 2006;101:234237.

  • 153.

    Kokka F, Bryant A, Brockbank E, Jeyarajah A. Surgical treatment of stage IA2 cervical cancer. Cochrane Database Syst Rev 2014:CD010870.

  • 154.

    Small W Jr., Strauss JB, Jhingran A. ACR Appropriateness Criteria(R) definitive therapy for early-stage cervical cancer. Am J Clin Oncol 2012;35:399405.

    • Search Google Scholar
    • Export Citation
  • 155.

    Raju SK, Papadopoulos AJ, Montalto SA. Fertility-sparing surgery for early cervical cancer-approach to less radical surgery. Int J Gynecol Cancer 2012;22:311317.

    • Search Google Scholar
    • Export Citation
  • 156.

    Li J, Wu X, Li X, Ju X. Abdominal radical trachelectomy: Is it safe for IB1 cervical cancer with tumors ≥ 2 cm? Gynecol Oncol 2013;131:8792.

  • 157.

    Landoni F, Maneo A, Cormio G. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol Oncol 2001;80:312.

    • Search Google Scholar
    • Export Citation
  • 158.

    Keys HM, Bundy BN, Stehman FB. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. Gynecol Oncol 2003;89:343353.

    • Search Google Scholar
    • Export Citation
  • 159.

    Kokka F, Bryant A, Brockbank E. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. Cochrane Database Syst Rev 2015;4:CD010260.

    • Search Google Scholar
    • Export Citation
  • 160.

    Colombo PE, Bertrand MM, Gutowski M. Total laparoscopic radical hysterectomy for locally advanced cervical carcinoma (stages IIB, IIA and bulky stages IB) after concurrent chemoradiation therapy: surgical morbidity and oncological results. Gynecol Oncol 2009;114:404409.

    • Search Google Scholar
    • Export Citation
  • 161.

    Touboul C, Uzan C, Mauguen A. Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer. Oncologist 2010;15:405415.

    • Search Google Scholar
    • Export Citation
  • 162.

    Huguet F, Cojocariu OM, Levy P. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion. Int J Radiat Oncol Biol Phys 2008;72:15081515.

    • Search Google Scholar
    • Export Citation
  • 163.

    Cetina L, Gonzalez-Enciso A, Cantu D. Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2-IIB cervical cancer patients. Ann Oncol 2013;24:20432047.

    • Search Google Scholar
    • Export Citation
  • 164.

    Kohler C, Mustea A, Marnitz S. Perioperative morbidity and rate of upstaging after laparoscopic staging for patients with locally advanced cervical cancer: results of a prospective randomized trial. Am J Obstet Gynecol 2015;213:503 e501–507.

    • Search Google Scholar
    • Export Citation
  • 165.

    Goff BA, Muntz HG, Paley PJ. Impact of surgical staging in women with locally advanced cervical cancer. Gynecol Oncol 1999;74:436442.

  • 166.

    Rose PG. Combination therapy: New treatment paradigm for locally advanced cervical cancer? Nat Rev Clin Oncol 2011;8:388390.

  • 167.

    Duenas-Gonzalez A, Zarba JJ, Patel F. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. J Clin Oncol 2011;29:16781685.

    • Search Google Scholar
    • Export Citation
  • 168.

    Thomas G. Are we making progress in curing advanced cervical cancer? J Clin Oncol 2011;29:16541656.

  • 169.

    Swisher EM, Swensen RE, Greer B. Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium. Gynecol Oncol 2006;101:429435.

    • Search Google Scholar
    • Export Citation
  • 170.

    Rose PG, Degeest K, McMeekin S, Fusco N. A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol 2007;107:274279.

    • Search Google Scholar
    • Export Citation
  • 171.

    Lutz ST, Chow EL, Hartsell WF, Konski AA. A review of hypofractionated palliative radiotherapy. Cancer 2007;109:14621470.

  • 172.

    Rotman M, Sedlis A, Piedmonte MR. A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 2006;65:169176.

    • Search Google Scholar
    • Export Citation
  • 173.

    Monk BJ, Wang J, Im S. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol 2005;96:721728.

    • Search Google Scholar
    • Export Citation
  • 174.

    Chernofsky MR, Felix JC, Muderspach LI. Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix. Gynecol Oncol 2006;100:288293.

    • Search Google Scholar
    • Export Citation
  • 175.

    Marchiole P, Buenerd A, Benchaib M. Clinical significance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgico-pathological study. Gynecol Oncol 2005;97:727732.

    • Search Google Scholar
    • Export Citation
  • 176.

    Trifiletti DM, Swisher-McClure S, Showalter TN. Postoperative chemoradiation therapy in high-risk cervical cancer: re-evaluating the findings of Gynecologic Oncology Group study 109 in a large, population-based cohort. Int J Radiat Oncol Biol Phys 2015;93:10321044.

    • Search Google Scholar
    • Export Citation
  • 177.

    Gong L, Lou JY, Wang P. Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2-IIB cervical cancer. Int J Gynaecol Obstet 2012;117:2326.

    • Search Google Scholar
    • Export Citation
  • 178.

    Eddy GL, Bundy BN, Creasman WT. Treatment of (“bulky”) stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group. Gynecol Oncol 2007;106:362369.

    • Search Google Scholar
    • Export Citation
  • 179.

    Rydzewska L, Tierney J, Vale CL, Symonds PR. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer. Cochrane Database Syst Rev 2010:CD007406.

    • Search Google Scholar
    • Export Citation
  • 180.

    Katsumata N, Yoshikawa H, Kobayashi H. Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102). Br J Cancer 2013;108:19571963.

    • Search Google Scholar
    • Export Citation
  • 181.

    Kim HS, Sardi JE, Katsumata N. Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an international collaborative meta-analysis. Eur J Surg Oncol 2013;39:115124.

    • Search Google Scholar
    • Export Citation
  • 182.

    Landoni F, Sartori E, Maggino T. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study. Gynecol Oncol 2014;132:611617.

    • Search Google Scholar
    • Export Citation
  • 183.

    Ye Q, Yuan HX, Chen HL. Responsiveness of neoadjuvant chemotherapy before surgery predicts favorable prognosis for cervical cancer patients: a meta-analysis. J Cancer Res Clin Oncol 2013;139:18871898.

    • Search Google Scholar
    • Export Citation
  • 184.

    Arbyn M, Dillner J. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening. J Clin Virol 2007;38:189197.

    • Search Google Scholar
    • Export Citation
  • 185.

    Rambout L, Hopkins L, Hutton B, Fergusson D. Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials. CMAJ 2007;177:469479.

    • Search Google Scholar
    • Export Citation
  • 186.

    Chan JK, Berek JS. Impact of the human papilloma vaccine on cervical cancer. J Clin Oncol 2007;25:29752982.

All Time Past Year Past 30 Days
Abstract Views 1 0 0
Full Text Views 17753 11875 669
PDF Downloads 6114 4392 188
EPUB Downloads 0 0 0